Published in Women's Health Weekly, June 26th, 2003
The researchers tested markers in 21 patients newly diagnosed with early- stage breast cancer and found that these markers could predict with 75% accuracy whether the chemotherapy would eradicate tumor cells.
"This study holds promise for designing therapeutics that maximize treatment success," said Rebecca Garcia, PhD, vice president of health sciences at the Susan G. Komen Breast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly